Jefferies Group upgraded shares of LyondellBasell (NYSE:LYB) from a hold rating to a buy rating in a report published on Wednesday, Marketbeat Ratings reports. The firm currently has $121.95 price target on the specialty chemicals company’s stock, up from their previous price target of $7
Oil driller ConocoPhillips (NYSE:COP) is benefiting from rising oil prices and rewarding investors with dividend hikes. However, the company's drilling-focused business hasn't been able to sustain a high dividend in the past, cutting the payment in 2016 amid low oil prices. This suggests that d
Russia isn’t just trying to sell its new airliner abroad. It might build it there, too.
State-owned military-industrial giant Rostec, which is responsible for exporting Russian technology, said Sunday that it has started talks to jointly produce a commercial plane overseas — potentially in the United Arab Emirates.
The short statement, which coincided with the start....More>>>
Ambarella (NASDAQ:AMBA) is primarily known for supplying image processing SoCs (system on chips) for GoPro’s (NASDAQ:GPRO) action cameras. As a result, Ambarella’s stock often rose and fell with GoPro’s in the past.
But over the past few quarters, Ambarella reduced its dependence on GoPro while increasing its presence in adjacent markets. That’s why Ambarella’s....More>>>
Though he campaigned for Hillary Clinton, financier Warren Buffett (Trades, Portfolio) divulged that he bought a lot of stocks following the election of President Donald Trump, and on Tuesday he revealed what they were.
WASHINGTON, DC – JUNE 14: Warren Buffett participates in a discussion during the White House Summit on the United State Of Women June 14, 2016 in Washington, DC. The....More>>>
Intersect ENT (NASDAQ:XENT) is a commercial drug-device company that has developed a drug releasing bioabsorbable implant technology, which enables targeted and sustained release of therapeutic agents. This technology is designed to help ear, nose and throat or ENT physicians to improve patient care, specifically aiding in the treatment of chronic sinusitis. According to....More>>>
Related LBY 20 Biggest Mid-Day Losers For Tuesday Mid-Day Market Update: NutriSystem Gains After Strong Q4 Results; Fiesta Restaurant Group Shares Plunge Libbey EPS of -$0.10 (Seeking Alpha) Related TGT Jim Cramer: Target's Executives Are Likely Wondering What The Heck Is Going On 20 Biggest....More>>>
Late Tuesday, Gilead Sciences (GILD) won a court ruling in its battle with Merck (MRK) over the intellectual property rights behind its blockbuster hepatitis-C drugs Harvoni and Sovaldi. Gabelli’s Jing He stands by her contention that Gilead is “the most undervalued stock” in biotech:
Gilead Sciences CEO John Milligan Victor J. Blue/Bloomberg News
We’ve said this to you before, but we’re going to say it here again.
If you haven’t already grabbed a stake in the SharesPost 100 Fund (PRIVX) – the investment pool with the goal of acquiring stakes in 100 of the very best late-stage startups – you still have time to make your move.
While the initial public offering (IPO)....More>>>
Geron (GERN) is a tiny biotech, <$1 billion market cap, with an oversized history and an undersized pipeline. Its CEO has managed to steer the company through the wilderness within clear sight of the promised land. He expects that by Q3 2018, Johnson & Johnson's (JNJ) subsidiary Janssen w
Cliffs Natural Resources (CLF) shares have been under pressure since March. The downside was very significant -- a stock that traded around $12 at its highs traded below $6 a few days ago. However, it appears as if the downside momentum has finally ended and Cliffs is able to return to the previo
Hunter Harrison is a hero in the railroad industry, a folk legend if you will, when it comes to turning around rail companies. He successfully turned around Canadian Pacific Railway (NYSE:CP) before jumping ship early to partner with activist investor Mantle Ridge to take on CSX (NYSE:CSX).
It's been an interesting few years for T-shirt manufacturer Delta Apparel (NYSEMKT:DLA). A huge spike in cotton prices in 2011 helped turn a near-$2 EPS in FY11 into a loss in FY12. (DLA fiscal years then ended in June; the company moved to September in 2013.) Delta managed to recover in FY13, ge